Hyejeong Jang
Overview
Explore the profile of Hyejeong Jang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Eggly S, Moore T, Baidoun F, Mattei L, Jang H, Kim S, et al.
Patient Educ Couns
. 2023 May;
113:107793.
PMID: 37207383
Objective: This descriptive, single-arm study assessed the implementation and patient perceptions of an evidence-based Question Prompt List (QPL), the ASQ brochure, across a network of oncology clinics in a diverse...
12.
Abada E, Jang H, Kim S, Abada O, Beydoun R
Ann Gastroenterol
. 2023 May;
36(3):321-326.
PMID: 37144022
Background: Medullary colonic carcinoma (MCC) is a rare and distinct phenotype of colorectal cancers characterized histologically by sheets of malignant cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm,...
13.
Jang H, Jung D, Bae W, Park Y, Lee D
J Chem Phys
. 2023 Apr;
158(13):134712.
PMID: 37031136
Semiconductor nanocrystals with an anisotropic morphology exhibit unique properties, most notably their linear polarization. The colloidal growth of semiconductor nanorods with core dots inside, also referred to as dot-in-rod (DIR)...
14.
Shama S, Jang H, Wang X, Zhang Y, Shahin N, Motawi T, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674549
Pathogenesis roles of phospholipids (PLs) in nonalcoholic fatty liver disease (NAFLD) remain incompletely understood. This study investigated the role of PLs in the progression of NAFLD among obese individuals via...
15.
Eggly S, Senft N, Kim S, Heath E, Jang H, Moore T, et al.
Cancer Med
. 2022 Dec;
12(7):8604-8613.
PMID: 36540051
Background: Cancer clinical trial participation is low and inequitable. Partnering Around Cancer Clinical Trials (PACCT) addressed systemic and interpersonal barriers through an observational study of eligibility and an intervention to...
16.
Shah H, Jang H, Kim S, Halwani A
Br J Haematol
. 2022 Nov;
200(5):579-586.
PMID: 36400571
We conducted a Surveillance, Epidemiology, and End Results Program (SEER-18) registry analysis of classical Hodgkin lymphoma (cHL) patients more than 60 years old and compared outcomes of those diagnosed between...
17.
Abada E, Jang H, Kim S, Ali-Fehmi R, Bandyopadhyay S
J Pathol Transl Med
. 2022 Oct;
56(6):342-353.
PMID: 36288741
Background: We aimed to study the clinicopathologic and immunohistochemical (IHC) (CD117, c-Myc, and p53) characteristics, and overall survival of primary and secondary breast angiosarcoma (BAS). Methods: This was a retrospective...
18.
Azar I, Yazdanpanah O, Jang H, Austin A, Kim S, Chi J, et al.
JAMA Netw Open
. 2022 Oct;
5(10):e2237699.
PMID: 36264573
Importance: The current standard of care for the treatment of small cell lung cancer (SCLC) is concurrent chemoradiation for patients with limited-stage SCLC (LS-SCLC) and chemoimmunotherapy for extensive-stage SCLC (ES-SCLC)....
19.
Burmeister J, Dominello M, Soulliere R, Baran G, Dess K, Loughery B, et al.
Int J Radiat Oncol Biol Phys
. 2022 Oct;
115(1):233-243.
PMID: 36243227
Purpose: The complex technological processes involved in radiation therapy can be intimidating to patients, causing increased treatment-related anxiety and reduced satisfaction. An intervention was implemented to provide direct consultations between...
20.
Abada E, Kim S, Dozier K, Fehmi O, Jang H, Fehmi Z, et al.
Cancer Treat Res Commun
. 2022 Sep;
33:100630.
PMID: 36058202
Background: Metaplastic breast carcinoma (MBC) is a rare histologic variant of breast cancer characterized by the presence of glandular and non-glandular components. The prognostic significance of estrogen receptor (ER) status...